Assisted Reproductive Technology Market Future Challenges and Industry Growth Outlook by 2020-2026

Assisted Reproductive Technology Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

With the expanding healthcare infrastructure, large-scale acceptance, and growing consumer awareness towards ART, assisted reproductive technology market is projected to witness a lucrative rate of growth over the forthcoming time period. The ART technology is essentially used for addressing the issue of infertility, for fulfilling the desire of bearing a biological child.

Additionally, ongoing technological advancements, new innovations and R&D initiatives are likely to drive the ART market growth in a prominent manner. Citing an instance, on 2nd July 2020, Kumamoto and Kyoto Universities in Japan reportedly announced a research collaboration for the development of a new technique for reducing cell damage and improving the IVF rates by use of cell sorter with microfluidic chip technology. The new technology can effectively be utilized for improving in-vitro fertilization.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/506

The in-vitro fertilization technology segment is slated to witness substantial gains over the coming years. The segment is likely to witness a CAGR of around 3.8% through the forecast time period due to improvements of procedures through utilization of numerous elements, high awareness, and high success rate and reliability. This procedure is concerned with the collection of woman’s eggs and male sperms. Both the egg and sperm are further left in the medical lab in a culture dish for letting the fertilization of the egg.

If fertilization occurs, then there is the likelihood of embryo transfer, in which an embryo is developed and placed inside the uterus of a woman. Similarly, in some cases numerous embryos might develop, which are frozen for later use mostly for transfer procedures.

The assisted reproductive technology market in Asia-Pacific is expected to witness a CAGR of around 5.8% over the forthcoming time period owing to factors such as expanding healthcare infrastructure, shift of child-bearing age, delayed pregnancy, and increasing percentage of working women.

Over the years, with rising awareness couples in APAC have turned towards ART fertility treatment,  the number is especially high in China. As per reliable data, there has been an increase in number of IVF cycles per year, exceeding beyond approximately 900,000. Similarly, patients with infertility also changed from looking for normal need for fertility solutions to a need for healthier babies, like preimplantation genetic screening and diagnosis, infertility screening, and pre-pregnancy screening among others.

Seeing the growing demand, several industry players are consolidating their position in the region. Citing an instance, recently, on 10th August, Jabrehoo, a renowned reproductive and genetic service organization, reportedly raised approximately $14.35 million in a series B round of financing directed by Apricot Capital. The firm is among the first one to introduce NGS technology into assisted reproduction, utilizing advanced technology across the region. Such measures would further increase the demand for ART across the region.

Some of the key industry players operating in the ART market include Vitrolife AB, Genea Limited, and Cooper Companies Inc., among many others. 

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/assisted-reproductive-technology-market

Partial Chapter of the Table of Content 

Chapter 5. Assisted Reproductive Technology Market, By Technology

5.1. Key segment trends

5.2. In-vitro fertilization (IVF)

5.2.1.  Market size, by region, 2015 - 2026 (USD Million)

5.2.2.  IVF with Intracytoplasmic Sperm Injection (ICSI)

5.2.2.1.    Market size, by region, 2015 – 2026 (USD Million)

5.2.3.  IVF without ICSI

5.2.3.1.    Market size, by region, 2015 – 2026 (USD Million)

5.3. Artificial Insemination – Intrauterine insemination (AI-IUI)

5.3.1.  Market size, by region, 2015 - 2026 (USD Million)

5.4. Frozen Embryo Replacement (FER)

5.4.1.  Market size, by region, 2015 - 2026 (USD Million)

5.5. Others

5.5.1.  Market size, by region, 2015 - 2026 (USD Million)

Chapter 6. Assisted Reproductive Technology Market, By End-use

6.1. Key segment trends

6.2. Hospitals

6.2.1.  Market size, by region, 2015 - 2026 (USD Million)

6.3. Fertility clinics

6.3.1.  Market size, by region, 2015 - 2026 (USD Million)

6.4. Others

6.4.1.  Market size, by region, 2015 - 2026 (USD Million)